Construction of Fe3O4-Loaded Mesoporous Carbon Systems for Controlled Drug Delivery

Magnetite (Fe3O4) nanoparticles as drug carriers can achieve precise drug target due to their magnetic property. However, they are easy to aggregate in the physiological environment, which obviously limits their application in drug delivery. The development of the Fe-MIL-88B-derived method to construct the Fe3O4-loaded mesoporous carbon (Fe3O4/carbon) system is a feasible strategy to solve the issue. First, iron atoms evenly distribute in the organic links through coordination bonds in Fe-MIL-88B. After the carbonization of Fe-MIL-88B, mesoporous carbon acts as a barrier to prevent the aggregation of Fe3O4 nanoparticles. Herein, Fe-MIL-88B particles were fabricated by the hydrothermal method and then pyrolyzed to construct mei Fe3O4/carbon systems. Results showed that Fe3O4 nanopartides uniformly in situ grew on mesoporous carbon generated by the carbonization of organic components. More encouragingly, the Fe3O4/carbon system loaded with DOX demonstrated pH-responsive DOX release, efficient delivery of DOX into cancer cells, and significant cancer cell killing ability. Therefore, the Fe3O4/carbon systems prepared by the Fe-MIL-88B-derived method might open up a way for targeted and controlled drug delivery.

Automated summary

Magnetite nanoparticles as drug carriers have precise drug targeting abilities but tend to aggregate in physiological environments. The Fe-MIL-88B-derived method of constructing Fe3O4-loaded mesoporous carbon systems provides a feasible solution to this issue and enables effective drug delivery. Fe-MIL-88B evenly distributes iron atoms through coordination bonds, and the mesoporous carbon generated after carbonization acts as a barrier against aggregation of Fe3O4 nanoparticles.